| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAFAU | LAFAYETTE ACQUISITION CORP | $10.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$13.43k | -0.00 | N/A | N/A | ||
| EFTY | ETOILES CAPITAL GROUP CO LTD | $15.02 | $27.57 | -45.51% | 326.52x | N/A | 109.64x | N/A | 0.20x | $1.55M | 0.56% | $888.19k | 0.05 | N/A | N/A | ||
| KLAR | KLARNA GROUP PLC | $36.91 | N/A | N/A | N/A | -63.78x | N/A | N/A | N/A | N/A | N/A | $2.34B | 3.25 | N/A | N/A | ||
| DKI | DARKIRIS INC | $0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $2.43M | 0.14 | N/A | N/A | ||
| STKE | SOL STRATEGIES INC | $2.85 | N/A | N/A | N/A | -4.17x | N/A | N/A | N/A | N/A | N/A | $74.01M | 3.59 | N/A | N/A | ||
| CHECU | CHENGHE ACQUISITION III CO | $9.98 | N/A | N/A | -499.00x | N/A | N/A | N/A | N/A | $0.00 | 0.00% | -$50.85k | -0.01 | N/A | N/A | ||
| YCY.U | AA MISSION ACQUISITION CORP II | $9.99 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$17.59k | -0.01 | N/A | N/A | ||
| DMIIU | DRUGS MADE IN AMERICA ACQUISITION II CORP | $10.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$214.12k | -0.00 | N/A | N/A | ||
| LKSPU | LAKE SUPERIOR ACQUISITION CORP | $10.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$147.49k | -0.04 | N/A | N/A | ||
| DLXY | DELIXY HOLDINGS LTD | $1.03 | $2.05 | -49.67% | 14.74x | N/A | 0.05x | N/A | 0.23x | $1.57M | 10.17% | $1.35M | 0.09 | N/A | N/A | ||
| LBRX | LB PHARMACEUTICALS INC | $16.50 | N/A | N/A | N/A | -5.25x | N/A | N/A | N/A | N/A | N/A | -$103.87M | -5.17 | N/A | N/A | ||
| EMPG | EMPRO GROUP INC | $17.36 | N/A | N/A | 157.82x | N/A | 25.31x | N/A | N/A | $52.92k | 0.04% | $741.21k | 0.09 | N/A | N/A | ||
| CEPF | CANTOR EQUITY PARTNERS IV INC | $10.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$44.39k | -0.00 | N/A | N/A | ||
| NSRX | NASUS PHARMA LTD | $8.00 | N/A | N/A | -36.36x | N/A | N/A | N/A | N/A | -$665.00k | -1.19% | -$3.21M | -0.46 | N/A | N/A | ||
| AEXA | AMERICAN EXCEPTIONALISM ACQUISITION CORP A | $11.31 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $7.58k | 0.00 | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.